Drug Toxicity Prediction Service

Inquiry

Drug Toxicity Prediction Service

Toxicity prediction is a key step in the drug development process. It helps identify and prioritize compounds that are most likely to be safe and effective for human use, while also reducing the risk of late-stage development failures and avoiding costly results. Computer drug toxicity prediction provides a cost-effective alternative to traditional animal testing. As an expert in computational biology, CD ComputaBio uses cutting-edge computer tools to improve drug safety for its customers.

Introduction to Drug Toxicity Prediction

Drug toxicity prediction is a critical part of the drug development process, which aims to evaluate the toxic side effects and adverse reactions that candidate drugs may cause. Traditional drug toxicity prediction relies on methods such as in vitro experiments, animal experiments, and clinical trials. Although these methods can provide direct toxicity information, the process is time-consuming, costly, and there are ethical challenges. With the rise of bioinformatics and computational biology, computational toxicology has gradually become an important tool for drug toxicity prediction.

Fig. 1 Drug toxicity prediction.Fig. 1 A machine learning model framework for drug toxicity prediction in vivo and in vitro. (Sharma B, et al.; 2023)

In silico drug toxicity prediction uses computer simulation, machine learning, and big data analysis to model and analyze large amounts of chemical structure and biological activity data to predict the potential toxicity of compounds. This method can quickly assess toxicological risks without animal testing or lengthy laboratory experiments. In addition, in silico toxicity prediction can also quickly screen a large number of compounds in the early stages of drug development to screen out candidate compounds that may be toxic, thereby avoiding costly late-stage failures.

Our Services

As part of our integrated in silico ADMET prediction service, in silico toxicity prediction provides critical data on the safety and efficacy of target compounds. At CD ComputaBio, our advanced models integrate AI-driven algorithms and quantitative structure-activity relationship (QSAR) technology to predict the toxicological properties of new compounds. These models enable us to predict a range of toxic effects, including cardiotoxicity, mutagenicity, carcinogenicity, and hepatotoxicity, to ensure that drug candidates are safe and meet regulatory standards.

Comprehensive Toxicity Prediction Model Construction

Our scientists use advanced machine learning and artificial intelligence algorithms to build toxicity prediction models for your specific compounds. In addition, a relationship model between chemical structure and toxicity is established based on quantitative structure-activity relationship (QSAR) technology.

Toxicity Mechanism Analysis

The plan aims to assist our customers in conducting in-depth studies on the toxicity mechanisms of compounds, reveal potential molecular targets and biological pathways, and provide a scientific basis for structural optimization and toxicity reduction of compounds.

High-Throughput Virtual Screening

We will also use computer simulation technology to assist customers in rapid screening of a large number of candidate compounds, identify and eliminate potential highly toxic compounds, and focus on candidates with higher safety.

ADMET Property Prediction

Toxicity prediction is part of our integrated ADMET prediction service. If you need, we also provide a comprehensive prediction of the ADMET properties of the compound, combined with pharmacokinetic parameters, to improve the in vivo effectiveness and safety of your compound.

  • Acute toxicity (LD50) prediction.
  • Chronic toxicity prediction.
  • Mutagenicity prediction.
  • Carcinogenicity prediction.
  • Cardiac toxicity prediction.
  • Renal toxicity prediction.
  • Reproductive toxicity prediction.
  • Hepatotoxicity prediction.
  • More

Workflow of Drug Toxicity Prediction

Data Collection and Integration

We first collect a large number of toxicology datasets, including historical data from in vivo, in vitro, and previous computer simulation studies. These datasets contain information on chemical structure, known toxicity, and biological interactions.

Toxicity Prediction Model Construction

We use state-of-the-art modeling techniques, including QSAR modeling, machine learning and artificial intelligence algorithms to build and train toxicity prediction models applicable to your target compounds.

Model Validation

After our model training is completed, it will be rigorously validated against known datasets to ensure its accuracy. Our validation process ensures reliable predictions and helps customers make data-driven decisions.

Toxicity Prediction and Reporting

We use validated models to predict the toxicity of new compounds. The results are presented in a clear and actionable report, allowing customers to confidently assess the safety of their compounds.

Advanced Modeling Technology

QSAR Modeling

We develop advanced QSAR models that establish quantitative relationships between the chemical structures of compounds and their biological activities or toxic effects.

Machine Learning

Our AI-based models use machine learning algorithms to identify patterns and relationships between compounds and their toxic effects.

Molecular Dynamics Simulations

We use MD simulations to study the interactions between compounds and biomacromolecules, such as proteins and DNA, to gain insight into the molecular mechanisms of toxicity.

CD ComputaBio's drug toxicity prediction service is designed to provide clients with valuable insights into the potential toxicity of compounds using powerful computational tools, helping them make informed decisions during drug discovery and development. Please don't hesitate to contact us, if you are interested in our services. Learn how our scientists can assist with your research projects and accelerate your path to success.

Reference:

  1. Sharma B, et al. Accurate clinical toxicity prediction using multi-task deep neural nets and contrastive molecular explanations. Sci Rep. 2023;13(1):4908.
* For Research Use Only.
Related Services
logo
Give us a free call

Send us an email

Copyright © CD ComputaBio. All Rights Reserved.
Top